August 31, 2026

Doximity, Inc. (DOCS): Investor Outlook Reveals 11.40% Potential Upside Amidst Strong Market Dynamics

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare information services industry, is capturing investor attention with its promising growth metrics and significant market presence. With a market capitalization..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 6.41% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with a robust market capitalization of $35.16 billion. As a major player in the healthcare industry, Royalty Pharma offers..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 29% Upside Potential

For investors eyeing the healthcare sector, Prestige Consumer Healthcare Inc. (NYSE: PBH) presents a compelling opportunity, with a notable potential upside of 29.22% based on the current average target price..

Universal Health Services, Inc. (UHS) Stock Analysis: Strong Revenue Growth and a 12.98% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) presents a compelling opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of $10.12 billion, this Pennsylvania-based company operates a..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 13.36% Potential Upside in the Diagnostics & Research Sector

Agilent Technologies, Inc. (NYSE: A), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, is capturing investor attention with a market cap of $43.38 billion...

Baxter International Inc. (BAX) Stock Analysis: Exploring a 9.94% Potential Upside Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently capturing investor attention with its diverse product portfolio and a notable potential upside of 9.94%. Headquartered..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.68% Upside Potential in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the medical distribution sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Market Challenges with Robust Revenue Growth

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to demonstrate resilience in the ever-evolving pharmaceutical landscape. With a market capitalization of $136 billion, the company maintains..

Penumbra, Inc. (PEN) Stock Analysis: Unraveling the 12.48% Potential Upside

Penumbra, Inc. (NYSE: PEN) stands as a formidable player in the healthcare sector, specializing in the design, development, and marketing of innovative medical devices. With a market capitalization of $12.67..

Guardant Health, Inc. (GH) Investor Outlook: A 20% Upside Potential Amidst Rapid Revenue Growth

Guardant Health, Inc. (GH) stands at the forefront of the precision oncology sector, offering innovative solutions in diagnostics and research. With a significant market capitalization of $21.67 billion, this Palo..

Elanco Animal Health (ELAN) Stock Analysis: Unveiling a 29% Upside Potential Amidst Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector’s drug manufacturing niche, has caught the attention of investors with its compelling growth prospects. The company, headquartered..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with a -15.14% Potential Downside

For investors keeping a keen eye on the medical devices industry, Bio-Rad Laboratories, Inc. (NYSE: BIO) presents a fascinating case study. With a market capitalization of $10.37 billion, Bio-Rad stands..

Bruker Corporation (BRKR) Stock Analysis: Exploring Growth Potential in the Healthcare Sector

Bruker Corporation (BRKR), a prominent player in the medical devices industry, has been making waves in the healthcare sector with its scientific instruments and analytical solutions. Headquartered in Billerica, Massachusetts,..

Ascendis Pharma A/S (ASND): Investor Outlook Reveals a Promising 27% Upside Potential in Biotech

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biopharmaceutical company, has been making significant waves in the healthcare sector, particularly within the biotechnology industry. With a robust market capitalization of $16.26..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatile Waters of TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a pioneering company in the healthcare sector, is capturing attention with its focus on Traditional Chinese Medicine (TCM) aimed at treating neurocognitive disorders. Headquartered..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 41.55% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its notable market presence and promising growth trajectory. With a market..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a Biotech Giant with 18.87% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands as a formidable entity in the biotechnology sector, commanding a significant market capitalization of $44.56 billion. Headquartered in Redwood City, California, the company is..

Stevanato Group S.p.A. (STVN) Stock Analysis: Navigating a Potential 18% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. With a robust market capitalization of $5.74 billion,..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 23% Upside Opportunity

HealthEquity, Inc. (NASDAQ: HQY) stands at the nexus of healthcare and technology, delivering innovative solutions through its comprehensive services platform. With a market capitalization of $7.97 billion, HealthEquity is a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Revenue Growth and Promising Potential Upside for Investors

TG Therapeutics, Inc. (NASDAQ: TGTX) has recently captured the attention of investors with its strong revenue growth and potential upside. This biotechnology company, based in Morrisville, North Carolina, specializes in..

Search

Funds

August 31, 2026

Search

Funds

August 31, 2026

FTSE 100

Funds